- Home
- IDXX
as 12-26-2024 4:00pm EST
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | WESTBROOK |
| Market Cap: | 35.5B | IPO Year: | 1991 |
| Target Price: | $539.63 | AVG Volume (30 days): | 588.1K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 10.36 | EPS Growth: | 5.57 |
| 52 Week Low/High: | $398.50 - $583.39 | Next Earning Date: | 02-03-2025 |
| Revenue: | $3,844,817,000 | Revenue Growth: | 7.16% |
| Revenue Growth (this year): | 8.09% | Revenue Growth (next year): | 7.25% |
Stock Insider Trading Activity of IDEXX Laboratories Inc. (IDXX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Vandebroek Sophie V. | IDXX | Director | Nov 27 '24 | Sell | $420.44 | 344 | $144,629.64 | 905 |
Latest IDEXX Laboratories Inc. News
IDXX Breaking Stock News: Dive into IDXX Ticker-Specific Updates for Smart Investing
Zacks
8 hours ago
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term
Argus Research
3 days ago
IDXX: Lowering target price to $434.00
Simply Wall St.
3 days ago
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly
Insider Monkey
6 days ago
Jim Cramer on IDEXX Laboratories (IDXX): Is This Pet Stock Poised for a Comeback?
GlobeNewswire
7 days ago
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX
Simply Wall St.
7 days ago
IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 9.3% CAGR delivered to shareholders
Argus Research
9 days ago
IDXX: Lowering target price to $448.00
Motley Fool
13 days ago
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025
Compare IDXX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IDXX IDEXX Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.